ArticleBlood2023

Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents.

Adam D Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.